Venus Remedies Limited
RESULTS FOR Q1 FY 2013-14
Q/E JUNE 2013
Venus
Remedies has declared reasonably
good results for the first quarter ending June, 2013.
Net
Sales for Q1 FY 14 stands at
Rs.126.65 Cr; up by 1.29% from Q4 FY 13 (Rs.125.03 Cr); and up by 13.04% from Q1 FY 13 (Rs.112.03 Cr).
Total
Expenditure for Q1 FY 14 stands at Rs.105.14 Cr; up by 1.83% from Q4 FY 13 (Rs.103.25
Cr); and up by 16.02% from Q1 FY 13 (Rs.90.62Cr).
Profit
before Interest, Dep. & Taxes
for Q1 FY 14 stands at Rs.21.51 Cr; down by -1.25%
from Q4 FY 13 (Rs.21.78 Cr); and up by 0.45% from Q1 FY 13 (Rs.21.41Cr).
Profit
before tax for Q1 FY 14 stands at Rs.16.21 Cr; up by 4.19%
from Q4 FY 14 (Rs.15.56 Cr); and up by 12.08% from Q1 FY 13 (Rs.14.46 Cr).
Tax Expenses for Q1 FY 14
stands at Rs.0.9 cr; down by -75.11% from Q4 FY 13 (Rs.3.6 Cr); and up by 115.11%
from Q1 FY 13 (Rs.0.417 Cr)
Net
Profit for Q1 FY 14 stands at Rs.15.31Cr; up by 28.1% from Q4 FY 13
(Rs.11.95 Cr); and up by 9.02% from Q1 FY 13 (Rs.14.05 Cr).
Face Value of the share is
Rs.10
Paid-up Equity stands at Rs.11.442 cr ;up by 8.54% from Q4 FY13 (Rs. 10.542Cr) and up by 17.45% from Q1 FY 13 (Rs.9.742
Cr).
Basic EPS for Q1 FY 14
stands at Rs.13.38; against Rs. 11.34
in Q4 FY 13; and Rs.14.42 in Q1 FY 13
Public Shareholding in the company stands at 56.26%; down from 65.58% in
Q1 FY 13.
CURRENT Market price : Rs.173.00 As on
06-AUG-2013 16:00:01
The Annualized EPS would be Rs.13.38 x 4 = 53.52
The PE Ratio would be 3.23; The performance of the company has been
gradually moving up. The current Profits and EPS are reasonably good. The
company is bagging new patents regularly. However, it must convert them into
sales and profits in a Big way. It has not yet tapped the large regulated
markets. However, given the impressive
array of Patents wide across the Globe, the company’s performance can be
expected to move up only in future and give good returns.
52 week
high/low price : Rs.358.45/140.00
Dividend History :
20-Sep-2012 : DIV RS. 3/- PER SHARE
22-Sep-2011 : DIV
RS.3/- PER SHARE
23-Sep-2010 : DIV
RS.3/- PER SHARE
17-Sep-2009 : DIV-RS.3/-
PER SHARE
12-Sep-2008 : DIV
- 40%
RESULTS
TABLE :
|
Venus Remedies
|
30-Jun-13
|
%Dif QoQ
|
31-Mar-13
|
31-Dec-12
|
30-Sep-12
|
%Dif Yoy
|
30-Jun-12
|
|
Net Sales
|
12664.5
|
1.29
|
12502.8
|
11162.4
|
11041.1
|
13.04
|
11203.4
|
|
Total Expenditure
|
10513.6
|
1.83
|
10324.7
|
9074.3
|
9000.1
|
16.02
|
9062.1
|
|
Profit before Interest,
Dep. & Taxes
|
2150.9
|
-1.25
|
2178.1
|
2088.1
|
2041
|
0.45
|
2141.3
|
|
Net Profit
|
1531.2
|
28.1
|
1195.3
|
1605.5
|
1509.2
|
9.02
|
1404.5
|
|
Total Income
|
12720.8
|
1.51
|
12531.7
|
11263.6
|
11081.3
|
13
|
11257.2
|
|
Changes in inventories
|
-28
|
-91.2
|
-318.3
|
5.5
|
-319
|
-90.59
|
-297.5
|
|
Cost of materials
|
7525
|
-4.22
|
7856.8
|
6353.5
|
6521.8
|
15.35
|
6523.7
|
|
Employee benefits
|
591.7
|
0.51
|
588.7
|
583.5
|
580.6
|
3.63
|
571
|
|
Depreciation
|
953.5
|
19.08
|
800.7
|
800.9
|
797.7
|
22.73
|
776.9
|
|
Other expenses
|
1471.4
|
5.34
|
1396.8
|
1330.9
|
1419
|
-1.12
|
1488
|
|
Total expenses
|
10513.6
|
1.83
|
10324.7
|
9074.3
|
9000.1
|
16.02
|
9062.1
|
|
Profit before tax
|
1620.9
|
4.19
|
1555.7
|
1694.4
|
1570.9
|
12.08
|
1446.2
|
|
Tax Expenses
|
89.7
|
-75.11
|
360.4
|
88.9
|
-
|
115.11
|
41.7
|
|
Net Profit
|
1531.2
|
28.1
|
1195.3
|
1605.5
|
1509.2
|
9.02
|
1404.5
|
|
Face Value
|
10
|
0
|
0
|
0
|
0
|
||
|
Paid-up Equity
|
1144.2
|
8.54
|
1054.2
|
974.2
|
974.2
|
17.45
|
974.2
|
|
Basic EPS
|
13.38
|
17.99
|
11.34
|
16.48
|
15.49
|
-7.21
|
14.42
|
|
Public Shareholding (%)
|
56.26
|
-7.86
|
61.06
|
66.08
|
66.08
|
-14.21
|
65.58
|
*
* * E
N D *
* *
No comments:
Post a Comment